Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas
This study is currently recruiting participants.
Study NCT00967226 Information provided by Children's Research Institute
First Received: August 26, 2009 No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemangioma of Infancy
Additional conditions recognized in this trial
Hemangioma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Vascular Tissue
Interventions listed in this trial
propranolol
Prednisolone
Additional drug interventions recognized in this trial
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone acetate
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Anti-Inflammatory Agents
Antiemetics
Antihypertensive Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Cardiovascular Agents
Central Nervous System Agents
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Children's Research Institute
Back to top of Main Content
